UK markets closed

Vifor Pharma AG (0RPD.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
135.50-1.65 (-1.20%)
At close: 4:19PM GMT
Currency in CHF

Valuation measures

Market cap (intra-day) 58.78B
Enterprise value 38.32B
Trailing P/E 24.52
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)4.98
Price/book (mrq)2.46
Enterprise value/revenue 34.72
Enterprise value/EBITDA 716.20

Trading information

Stock price history

Beta (5Y monthly) 1.24
52-week change 3N/A
S&P500 52-week change 345.93%
52-week high 3137.40
52-week low 3135.20
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 564.84M
Implied shares outstanding 6N/A
Float 46.6M
% held by insiders 128.08%
% held by institutions 138.31%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.00
Trailing annual dividend yield 31.46%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Dec 2020

Profitability

Profit margin 20.41%
Operating margin (ttm)17.78%

Management effectiveness

Return on assets (ttm)3.86%
Return on equity (ttm)6.13%

Income statement

Revenue (ttm)1.76B
Revenue per share (ttm)27.16
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)1.06B
EBITDA 513.3M
Net income avi to common (ttm)138.7M
Diluted EPS (ttm)5.53
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)734.4M
Total cash per share (mrq)11.32
Total debt (mrq)609.7M
Total debt/equity (mrq)15.18
Current ratio (mrq)2.96
Book value per share (mrq)55.04

Cash flow statement

Operating cash flow (ttm)423.8M
Levered free cash flow (ttm)79.34M